F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
Agenda
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
To read the full story from the source: New York Times – Home
